Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Continuing Medical Education Questions: November 2019.

Moawad FJ.

Am J Gastroenterol. 2019 Nov;114(11):1711. doi: 10.14309/ajg.0000000000000451.

PMID:
31688062
2.

Continuing Medical Education Questions: March 2019.

Moawad FJ.

Am J Gastroenterol. 2019 Mar;114(3):380. doi: 10.14309/ajg.0000000000000175.

PMID:
30839390
3.

New Developments in the Diagnosis and Treatment of Eosinophilic Esophagitis.

Nhu QM, Moawad FJ.

Curr Treat Options Gastroenterol. 2019 Mar;17(1):48-62. doi: 10.1007/s11938-019-00216-7. Review.

PMID:
30707411
4.

Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium.

Desai M, Lieberman DA, Kennedy KF, Hamade N, Thota P, Parasa S, Gorrepati VS, Bansal A, Gupta N, Gaddam S, Young PE, Mathur S, Moawad FJ, Cash BD, Sampliner R, Vargo JJ, Falk GW, Sharma P.

Gastrointest Endosc. 2019 Feb;89(2):257-263.e3. doi: 10.1016/j.gie.2018.09.041. Epub 2018 Oct 17.

PMID:
30342028
5.

The Anti-α4β7 Integrin Therapeutic Antibody for Inflammatory Bowel Disease, Vedolizumab, Ameliorates Eosinophilic Esophagitis: a Novel Clinical Observation.

Nhu QM, Chiao H, Moawad FJ, Bao F, Konijeti GG.

Am J Gastroenterol. 2018 Aug;113(8):1261-1263. doi: 10.1038/s41395-018-0145-1. Epub 2018 Jun 12. No abstract available.

PMID:
29895980
6.

Metastatic Cervical Cancer Causing Esophageal Compression and Dysphagia.

Jahromi BM, Nhu QM, Moawad FJ.

Clin Gastroenterol Hepatol. 2019 Jul;17(8):A41-A42. doi: 10.1016/j.cgh.2018.04.011. Epub 2018 Apr 12. No abstract available.

PMID:
29654914
7.

Eosinophilic Esophagitis: Incidence and Prevalence.

Moawad FJ.

Gastrointest Endosc Clin N Am. 2018 Jan;28(1):15-25. doi: 10.1016/j.giec.2017.07.001. Epub 2017 Aug 25. Review.

PMID:
29129296
8.

Editorial: oesophageal dilation in eosinophilic oesophagitis-can and should, but when and how? Authors' reply.

Moawad FJ, Lucendo AJ, Molina-Infante J.

Aliment Pharmacol Ther. 2017 Sep;46(5):558. doi: 10.1111/apt.14233. No abstract available.

9.

Systematic review with meta-analysis: endoscopic dilation is highly effective and safe in children and adults with eosinophilic oesophagitis.

Moawad FJ, Molina-Infante J, Lucendo AJ, Cantrell SE, Tmanova L, Douglas KM.

Aliment Pharmacol Ther. 2017 Jul;46(2):96-105. doi: 10.1111/apt.14123. Epub 2017 May 17. Review.

10.

Continuing Medical Education Questions: February 2017.

Moawad FJ.

Am J Gastroenterol. 2017 Feb;112(2):239. doi: 10.1038/ajg.2016.607. No abstract available.

PMID:
28154398
11.

Eosinophilic esophagitis: current perspectives from diagnosis to management.

Moawad FJ, Cheng E, Schoepfer A, Al-Haddad S, Bellizzi AM, Dawson H, El-Zimaity H, Guindi M, Penagini R, Safrooneva E, Chehade M.

Ann N Y Acad Sci. 2016 Sep;1380(1):204-217. doi: 10.1111/nyas.13164. Epub 2016 Jul 28. Review.

PMID:
27467185
12.

Sloughing esophagitis: a spectacular histologic and endoscopic disease without a uniform clinical correlation.

Moawad FJ, Appleman HD.

Ann N Y Acad Sci. 2016 Sep;1380(1):178-182. doi: 10.1111/nyas.13112. Epub 2016 Jul 6. Review.

13.

Managing eosinophilic esophagitis: challenges and solutions.

Shah NA, Albert DM, Hall NM, Moawad FJ.

Clin Exp Gastroenterol. 2016 Sep 16;9:281-290. eCollection 2016. Review.

14.

Subclonal diversity arises early even in small colorectal tumours and contributes to differential growth fates.

Sievers CK, Zou LS, Pickhardt PJ, Matkowskyj KA, Albrecht DM, Clipson L, Bacher JW, Pooler BD, Moawad FJ, Cash BD, Reichelderfer M, Vo TN, Newton MA, Larget BR, Halberg RB.

Gut. 2017 Dec;66(12):2132-2140. doi: 10.1136/gutjnl-2016-312232. Epub 2016 Sep 8.

15.

Longitudinal Evaluation of Noninvasive Biomarkers for Eosinophilic Esophagitis.

Min SB, Nylund CM, Baker TP, Ally M, Reinhardt B, Chen YJ, Nazareno L, Moawad FJ.

J Clin Gastroenterol. 2017 Feb;51(2):127-135. doi: 10.1097/MCG.0000000000000621.

PMID:
27479142
16.

Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis.

Albert D, Heifert TA, Min SB, Maydonovitch CL, Baker TP, Chen YJ, Moawad FJ.

Dig Dis Sci. 2016 Jul;61(7):1996-2001. doi: 10.1007/s10620-016-4110-9. Epub 2016 Apr 19.

PMID:
27093866
17.

Reply.

Cheng FK, Moawad FJ.

Clin Gastroenterol Hepatol. 2016 Jul;14(7):1061. doi: 10.1016/j.cgh.2016.03.016. Epub 2016 Mar 17. No abstract available.

PMID:
26997264
18.

An Overview of the Diagnosis and Management of Eosinophilic Esophagitis.

Singla MB, Moawad FJ.

Clin Transl Gastroenterol. 2016 Mar 17;7:e155. doi: 10.1038/ctg.2016.4. Review.

19.

Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis.

Molina-Infante J, Bredenoord AJ, Cheng E, Dellon ES, Furuta GT, Gupta SK, Hirano I, Katzka DA, Moawad FJ, Rothenberg ME, Schoepfer A, Spechler SJ, Wen T, Straumann A, Lucendo AJ; PPI-REE Task Force of the European Society of Eosinophilic Oesophagitis (EUREOS).

Gut. 2016 Mar;65(3):524-31. doi: 10.1136/gutjnl-2015-310991. Epub 2015 Dec 18.

20.

Early Comparison of Inflammatory vs. Fibrostenotic Phenotype in Eosinophilic Esophagitis in a Multicenter Longitudinal Study.

Singla MB, Chehade M, Brizuela D, Maydonovitch CL, Chen YJ, Riffle ME, Achem SR, Moawad FJ.

Clin Transl Gastroenterol. 2015 Dec 17;6:e132. doi: 10.1038/ctg.2015.62.

21.

Long-Term Loss of Response in Proton Pump Inhibitor-Responsive Esophageal Eosinophilia Is Uncommon and Influenced by CYP2C19 Genotype and Rhinoconjunctivitis.

Molina-Infante J, Rodriguez-Sanchez J, Martinek J, van Rhijn BD, Krajciova J, Rivas MD, Barrio J, Moawad FJ, Martinez-Alcalá C, Bredenoord AJ, Zamorano J, Dellon ES.

Am J Gastroenterol. 2015 Nov;110(11):1567-75. doi: 10.1038/ajg.2015.314. Epub 2015 Sep 29.

PMID:
26416193
22.

Effects of Race and Sex on Features of Eosinophilic Esophagitis.

Moawad FJ, Dellon ES, Achem SR, Ljuldjuraj T, Green DJ, Maydonovitch CL, Brizuela DR, Gupta SK, Chehade M.

Clin Gastroenterol Hepatol. 2016 Jan;14(1):23-30. doi: 10.1016/j.cgh.2015.08.034. Epub 2015 Sep 4.

PMID:
26343181
23.

Editorial: proton pump inhibitor-responsive oesophageal eosinophilia - two different phenotypes? - Author's reply.

Moawad FJ.

Aliment Pharmacol Ther. 2015 Aug;42(4):487-8. doi: 10.1111/apt.13289. No abstract available.

24.

Comparison of eotaxin-3 biomarker in patients with eosinophilic oesophagitis, proton pump inhibitor-responsive oesophageal eosinophilia and gastro-oesophageal reflux disease.

Moawad FJ, Wells JM, Johnson RL, Reinhardt BJ, Maydonovitch CL, Baker TP.

Aliment Pharmacol Ther. 2015 Jul;42(2):231-8. doi: 10.1111/apt.13258. Epub 2015 May 24.

25.

Editorial: Is eosinophilic oesophagitis different to proton pump inhibitor-responsive oesophageal eosinophilia?

Molina-Infante J, Moawad FJ, van Rhijn BD.

Aliment Pharmacol Ther. 2015 May;41(10):1023-4. doi: 10.1111/apt.13165. No abstract available.

26.

Lessons for conducting health development at the tactical level.

Wilson RL, Moawad FJ, Hartzell JD.

Mil Med. 2015 Apr;180(4):368-73. doi: 10.7205/MILMED-D-14-00319. No abstract available.

PMID:
25826340
27.

Infliximab-induced anterior uveitis in a patient with ulcerative Colitis.

Singla MB, Hodge DK, Moawad FJ.

J Crohns Colitis. 2015 May;9(5):432. doi: 10.1093/ecco-jcc/jjv030. Epub 2015 Feb 16. No abstract available.

PMID:
25690667
28.

Barrett's oesophagus length is established at the time of initial endoscopy and does not change over time: results from a large multicentre cohort.

Moawad FJ, Young PE, Gaddam S, Vennalaganti P, Thota PN, Vargo J, Cash BD, Falk GW, Sampliner RE, Lieberman D, Sharma P.

Gut. 2015 Dec;64(12):1874-80. doi: 10.1136/gutjnl-2014-308552. Epub 2015 Feb 4.

PMID:
25652086
29.

Categorization of patients with reflux symptoms referred for pH and impedance testing while off therapy.

Cheng FK, Albert DM, Maydonovitch CL, Wong RK, Moawad FJ.

Clin Gastroenterol Hepatol. 2015 May;13(5):867-73. doi: 10.1016/j.cgh.2014.10.018. Epub 2014 Oct 25.

PMID:
25445765
30.

Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation.

Wen T, Dellon ES, Moawad FJ, Furuta GT, Aceves SS, Rothenberg ME.

J Allergy Clin Immunol. 2015 Jan;135(1):187-97. doi: 10.1016/j.jaci.2014.08.043. Epub 2014 Oct 19.

31.

Pharmacologic treatments for esophageal disorders.

Blackshaw LA, Bordin DS, Brock C, Brokjaer A, Drewes AM, Farmer AD, Krarup AL, Lottrup C, Masharova AA, Moawad FJ, Olesen AE.

Ann N Y Acad Sci. 2014 Sep;1325:23-39. doi: 10.1111/nyas.12520.

PMID:
25266012
32.

Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis.

Schoepfer AM, Straumann A, Panczak R, Coslovsky M, Kuehni CE, Maurer E, Haas NA, Romero Y, Hirano I, Alexander JA, Gonsalves N, Furuta GT, Dellon ES, Leung J, Collins MH, Bussmann C, Netzer P, Gupta SK, Aceves SS, Chehade M, Moawad FJ, Enders FT, Yost KJ, Taft TH, Kern E, Zwahlen M, Safroneeva E; International Eosinophilic Esophagitis Activity Index Study Group.

Gastroenterology. 2014 Dec;147(6):1255-66.e21. doi: 10.1053/j.gastro.2014.08.028. Epub 2014 Aug 23.

33.

A randomized controlled study comparing room air with carbon dioxide for abdominal pain, distention, and recovery time in patients undergoing colonoscopy.

Chen YJ, Lee J, Puryear M, Wong RK, Lake JM, Maydonovitch CL, Belle L, Moawad FJ.

Gastroenterol Nurs. 2014 Jul-Aug;37(4):273-8. doi: 10.1097/SGA.0000000000000054.

PMID:
25078041
34.

Prevalence of eosinophilic esophagitis in a United States military health-care population.

Ally MR, Maydonovitch CL, Betteridge JD, Veerappan GR, Moawad FJ.

Dis Esophagus. 2015 Aug-Sep;28(6):505-11. doi: 10.1111/dote.12229. Epub 2014 May 15.

PMID:
24827543
35.

Letter: distinguishing PPI-responsive oesophageal eosinophilia from eosinophilic esophagitis - still a long way to go; authors' reply.

Moawad FJ.

Aliment Pharmacol Ther. 2014 May;39(10):1249-50. doi: 10.1111/apt.12725. No abstract available.

36.

Commentary: the proton pump inhibitor test - does it have a role in eosinophilic oesophagitis? Authors' reply.

Moawad FJ, Schoepfer AM.

Aliment Pharmacol Ther. 2014 Apr;39(8):897-8. doi: 10.1111/apt.12676. No abstract available.

37.

Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings.

Moawad FJ, Schoepfer AM, Safroneeva E, Ally MR, Chen YJ, Maydonovitch CL, Wong RK.

Aliment Pharmacol Ther. 2014 Mar;39(6):603-8. doi: 10.1111/apt.12636. Epub 2014 Jan 26.

38.

The tug sign: an endoscopic feature of eosinophilic esophagitis.

Moawad FJ, Robinson CL, Veerappan GR, Summers TA, Maydonovitch CL, Wong RKh.

Am J Gastroenterol. 2013 Dec;108(12):1938-9. doi: 10.1038/ajg.2013.252. No abstract available.

PMID:
24300877
39.

The sloughing esophagus: a report of five cases.

Albert DM, Ally MR, Moawad FJ.

Am J Gastroenterol. 2013 Nov;108(11):1816-7. doi: 10.1038/ajg.2013.230. No abstract available.

PMID:
24192964
40.

Cryotherapy for treatment of radiation proctitis.

Moawad FJ, Horwhat JD.

Gastrointest Endosc. 2014 Feb;79(2):209-10. doi: 10.1016/j.gie.2013.09.019. Epub 2013 Oct 18. No abstract available.

PMID:
24140130
41.

Meta-analysis: the safety and efficacy of dilation in eosinophilic oesophagitis.

Moawad FJ, Cheatham JG, DeZee KJ.

Aliment Pharmacol Ther. 2013 Oct;38(7):713-20. doi: 10.1111/apt.12438. Epub 2013 Aug 5. Review.

42.

The dose of omeprazole required to achieve adequate intraesophageal acid suppression in patients with gastroesophageal junction specialized intestinal metaplasia and Barrett's esophagus.

Watson JT, Moawad FJ, Veerappan GR, Bassett JT, Maydonovitch CL, Horwhat JD, Wong RK.

Dig Dis Sci. 2013 Aug;58(8):2253-60. doi: 10.1007/s10620-013-2763-1. Epub 2013 Jul 4.

PMID:
23824407
43.

Reflux episodes detected by impedance in patients on and off esomeprazole: a randomised double-blinded placebo-controlled crossover study.

Moawad FJ, Betteridge JD, Boger JA, Cheng FK, Belle LS, Chen YJ, Maydonovitch CL, Wong RK.

Aliment Pharmacol Ther. 2013 May;37(10):1011-8. doi: 10.1111/apt.12301. Epub 2013 Apr 7.

44.

Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia.

Moawad FJ, Veerappan GR, Dias JA, Baker TP, Maydonovitch CL, Wong RK.

Am J Gastroenterol. 2013 Mar;108(3):366-72. doi: 10.1038/ajg.2012.443. Epub 2013 Feb 12.

PMID:
23399553
45.

Efficacy of cryospray ablation for the treatment of chronic radiation proctitis in a pilot study.

Moawad FJ, Maydonovitch CL, Horwhat JD.

Dig Endosc. 2013 Mar;25(2):174-9. doi: 10.1111/j.1443-1661.2012.01355.x. Epub 2012 Jul 27.

PMID:
23362977
46.

Actively bleeding dieulafoy lesion identified in a critically ill patient only after the use of hydrogen peroxide.

Kwok RM, Damiano MN, Moawad FJ.

Am J Gastroenterol. 2012 Sep;107(9):1445-6. doi: 10.1038/ajg.2012.171. No abstract available.

PMID:
22951885
47.

Race may play a role in the clinical presentation of eosinophilic esophagitis.

Moawad FJ, Veerappan GR, Dias JA, Maydonovitch CL, Wong RK.

Am J Gastroenterol. 2012 Aug;107(8):1263; author reply 1263-4. doi: 10.1038/ajg.2012.176. No abstract available.

PMID:
22859003
48.

Safety of dilation in adults with eosinophilic esophagitis.

Ally MR, Dias J, Veerappan GR, Maydonovitch CL, Wong RK, Moawad FJ.

Dis Esophagus. 2013 Apr;26(3):241-5. doi: 10.1111/j.1442-2050.2012.01363.x. Epub 2012 Jun 7.

PMID:
22676406
49.

Screening CT colonography: multicenter survey of patient experience, preference, and potential impact on adherence.

Pooler BD, Baumel MJ, Cash BD, Moawad FJ, Riddle MS, Patrick AM, Damiano M, Lee MH, Kim DH, Muñoz del Rio A, Pickhardt PJ.

AJR Am J Roentgenol. 2012 Jun;198(6):1361-6. doi: 10.2214/AJR.11.7671.

50.

Role of the battalion surgeon in the Iraq and Afghanistan War.

Moawad FJ, Wilson R, Kunar MT, Hartzell JD.

Mil Med. 2012 Apr;177(4):412-6.

PMID:
22594131

Supplemental Content

Loading ...
Support Center